Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

The effect of body mass index on surgical outcomes and survival following pelvic exenteration.

Iglesias DA, Westin SN, Rallapalli V, Huang M, Fellman B, Urbauer D, Frumovitz M, Ramirez PT, Soliman PT.

Gynecol Oncol. 2012 May;125(2):336-42. doi: 10.1016/j.ygyno.2012.01.010. Epub 2012 Jan 16.

2.

Pelvic exenteration: impact of age on surgical and oncologic outcomes.

Huang M, Iglesias DA, Westin SN, Fellman B, Urbauer D, Schmeler KM, Frumovitz M, Ramirez PT, Soliman PT.

Gynecol Oncol. 2014 Jan;132(1):114-8. doi: 10.1016/j.ygyno.2013.11.014. Epub 2013 Nov 18.

3.

Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.

Jäger L, Nilsson PJ, Rådestad AF.

Int J Gynecol Cancer. 2013 May;23(4):755-62. doi: 10.1097/IGC.0b013e318287a874. Review.

PMID:
23407096
4.
5.

Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.

Benn T, Brooks RA, Zhang Q, Powell MA, Thaker PH, Mutch DG, Zighelboim I.

Gynecol Oncol. 2011 Jul;122(1):14-8. doi: 10.1016/j.ygyno.2011.03.003. Epub 2011 Mar 27.

6.
7.

Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.

Höckel M, Sclenger K, Hamm H, Knapstein PG, Hohenfellner R, Rösler HP.

Cancer. 1996 May 1;77(9):1918-33.

8.

Retrospective review of pelvic malignancies undergoing total pelvic exenteration.

Kuhrt MP, Chokshi RJ, Arrese D, Martin EW Jr.

World J Surg Oncol. 2012 Jun 15;10:110. doi: 10.1186/1477-7819-10-110.

9.

Overall survival after pelvic exenteration for gynecologic malignancy.

Westin SN, Rallapalli V, Fellman B, Urbauer DL, Pal N, Frumovitz MM, Ramondetta LM, Bodurka DC, Ramirez PT, Soliman PT.

Gynecol Oncol. 2014 Sep;134(3):546-51. doi: 10.1016/j.ygyno.2014.06.034. Epub 2014 Jul 9.

10.

Surgical results of pelvic exenteration in the treatment of gynecologic cancer.

Petruzziello A, Kondo W, Hatschback SB, Guerreiro JA, Filho FP, Vendrame C, Luz M, Ribeiro R.

World J Surg Oncol. 2014 Sep 8;12:279. doi: 10.1186/1477-7819-12-279.

11.

Pelvic exenteration with curative intent for recurrent uterine malignancies.

Khoury-Collado F, Einstein MH, Bochner BH, Alektiar KM, Sonoda Y, Abu-Rustum NR, Brown CL, Gardner GJ, Barakat RR, Chi DS.

Gynecol Oncol. 2012 Jan;124(1):42-7. doi: 10.1016/j.ygyno.2011.09.031. Epub 2011 Oct 20.

PMID:
22014627
12.

Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.

Moreno-Palacios E, Diestro MD, De Santiago J, Hernández A, Zapardiel I.

Int J Gynecol Cancer. 2015 Jul;25(6):1109-14. doi: 10.1097/IGC.0000000000000435.

PMID:
25853383
13.

Pelvic exenterations for gynecological malignancies: a study of 36 cases.

Kaur M, Joniau S, D'Hoore A, Van Calster B, Van Limbergen E, Leunen K, Penninckx F, Van Poppel H, Amant F, Vergote I.

Int J Gynecol Cancer. 2012 Jun;22(5):889-96. doi: 10.1097/IGC.0b013e31824eb8cd.

PMID:
22617477
14.

Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.

Fotopoulou C, Neumann U, Kraetschell R, Schefold JC, Weidemann H, Lichtenegger W, Sehouli J.

J Surg Oncol. 2010 May 1;101(6):507-12. doi: 10.1002/jso.21518.

PMID:
20401918
15.

Reconstruction of the pelvic floor and the vagina after total pelvic exenteration using the transverse musculocutaneous gracilis flap.

Kaartinen IS, Vuento MH, Hyöty MK, Kallio J, Kuokkanen HO.

J Plast Reconstr Aesthet Surg. 2015 Jan;68(1):93-7. doi: 10.1016/j.bjps.2014.08.059. Epub 2014 Sep 16.

PMID:
25305732
16.

[Laparoscopy-assisted vaginal pelvic exenteration].

Ferron G, Querleu D, Martel P, Chopin N, Soulié M.

Gynecol Obstet Fertil. 2006 Dec;34(12):1131-6. Epub 2006 Nov 28. French.

PMID:
17134933
17.

Pelvic exenteration for primary and recurrent gynaecological malignancies.

de Wilt JH, van Leeuwen DH, Logmans A, Verhoef C, Kirkels WJ, Vermaas M, Ansink AC.

Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):243-8. Epub 2006 Sep 6.

PMID:
16950559
18.

Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer.

Roos EJ, Van Eijkeren MA, Boon TA, Heintz AP.

Int J Gynecol Cancer. 2005 Jul-Aug;15(4):624-9.

PMID:
16014116
19.

Postoperative outcomes after continent versus incontinent urinary diversion at the time of pelvic exenteration for gynecologic malignancies.

Urh A, Soliman PT, Schmeler KM, Westin S, Frumovitz M, Nick AM, Fellman B, Urbauer DL, Ramirez PT.

Gynecol Oncol. 2013 Jun;129(3):580-5. doi: 10.1016/j.ygyno.2013.02.024. Epub 2013 Feb 26.

20.

Supplemental Content

Support Center